Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Trading Halts

Regulus Therapeutics (RGLS) PT Lowered to $0.50 at Wells FargoJuly 6, 2018 8:27 AM Regulus Therapeutics (RGLS) Falls 38% as Trading ResumesJuly 5, 2018 5:33 PM Regulus Therapeutics (RGLS) to Resume Trading at 5:30 pm ETJuly 5, 2018 5:03 PM Regulus Announces Strategic Update and Corporate RestructuringJuly 5, 2018 5:00 PM Regulus Therapeutics (RGLS) Halted, News PendingJuly 5, 2018 4:56 PM